| Literature DB >> 27754484 |
A Kibleur1,2, G Gras-Combe1,2, D Benis1,2, J Bastin1,2, T Bougerol1,2,3, S Chabardès1,2,4, M Polosan1,2,3, O David1,2.
Abstract
High-frequency deep brain stimulation of the subthalamic nucleus can be used to treat severe obsessive-compulsive disorders that are refractory to conventional treatments. The mechanisms of action of this approach possibly rely on the modulation of associative-limbic subcortical-cortical loops, but remain to be fully elucidated. Here in 12 patients, we report the effects of high-frequency stimulation of the subthalamic nucleus on behavior, and on electroencephalographic responses and inferred effective connectivity during motor inhibition processes involved in the stop signal task. First, we found that patients were faster to respond and had slower motor inhibition processes when stimulated. Second, the subthalamic stimulation modulated the amplitude and delayed inhibition-related electroencephalographic responses. The power of reconstructed cortical current densities decreased in the stimulation condition in a parietal-frontal network including cortical regions of the inhibition network such as the superior parts of the inferior frontal gyri and the dorsolateral prefrontal cortex. Finally, dynamic causal modeling revealed that the subthalamic stimulation was more likely to modulate efferent connections from the basal ganglia, modeled as a hidden source, to the cortex. The connection from the basal ganglia to the right inferior frontal gyrus was significantly decreased by subthalamic stimulation. Beyond motor inhibition, our study thus strongly suggests that the mechanisms of action of high-frequency subthalamic stimulation are not restricted to the subthalamic nucleus, but also involve the modulation of distributed subcortical-cortical networks.Entities:
Mesh:
Year: 2016 PMID: 27754484 PMCID: PMC5315551 DOI: 10.1038/tp.2016.192
Source DB: PubMed Journal: Transl Psychiatry ISSN: 2158-3188 Impact factor: 6.222
Clinical and demographic information on patients
| 1 | M | 46 | 39 | 18 | 71 | Checker | 37 | Fluvoxamine 200 mg per day Lorazepam 4 mg per day |
| 2 | F | 49 | 42 | 25 | 64 | Washer | 30 | Aripiprazole 30 mg per day Olanzapine 5 mg per day Escitalopram 20 mg per day Clomipramine 75 mg per day |
| 3 | M | 39 | 36 | 17 | 32 | Washer/ordering | 32 | Paroxetine 60 mg per day |
| 4 | F | 53 | 49 | 39 | 51 | Checker | 35 | Fluoxetine 20 mg per day Clomipramine 25 mg per day |
| 5 | M | 37 | 34 | 13 | 22 | Checker/repeater | 32 | Clomipramine 150 mg per day Oxazepam 175 mg per day Alimemazine 50 mg per day |
| 6 | F | 41 | 38 | 11 | 35 | Washer | 36 | None |
| 7 | F | 43 | 40 | 15 | 32 | Washer | 36 | Fluvoxamine 200 mg per day Hydroxyzine 50 mg per day Clomipramine 25 mg per day |
| 8 | F | 41 | 37 | 5 | 44 | Checker | 32 | Venlafaxine 37.5 mg per day Clotiazepam 1.5 mg per day |
| 9 | M | 30 | 27 | 10 | 25 | Checker/washer | 38 | Sertraline 50 mg per day Aripiprazole 20 mg per day Methyphenidate 60 mg per day Pitolisant 20 mg per day |
| 10 | F | 56 | 52 | 25 | 51 | Washer | 40 | Zopiclone 7.5 mg per day Aripiprazole 2.5 mg per day Hydroxyzine 100 mg per day |
| 11 | F | 33 | 33 | 21 | 5 | Checker | 30 | Venlafaxine 150 mg per day |
| 12 | F | 33 | 33 | 26 | 25 | Checker | 34 | Fluoxetine 20 mg per day Levothyroxine 125 μg per day |
Abbreviations: DBS, deep brain stimulation; F, female; M, male; OCD, obsessive-compulsive disorder; YBOCS, Yale-Brown Obsessive Compulsive Scale.
Figure 1Four conditions of the stop signal task: Go, STOP, Go Fast (GF) and Go Certain (GC). SSD, stop signal delay.
Figure 2Grand average of the global field power (low-pass-filtered at 10 Hz; ±s.e.m.) for the different conditions: ON stimulation (in red) and OFF stimulation (in blue) (a) in the successful stop (SS) trials and (b) unsuccessful stop (US) trials. (c) Scalp topographies of the data in ON and OFF stimulation conditions for SS and US trials at three latencies: 100 ms (time window: 75-125 ms), 200 ms (time window: 175–225 ms) and 300 ms (time window: 275-325 ms). Significant (0.01 uncorrected) sensors are indicated by dots in bold. GFP, global field power; SSRT, stop signal reaction time.
Figure 3Global network after source reconstruction for successful stop trials in (a) ON DBS condition and (b) OFF DBS condition. The activated areas common to the 12 patients significantly (P<0.005) are reported as T values on the cortical surface on the two windows of interest: centered on the individual N200 and P300 peak latencies. (c) Contrast T maps of the stimulation effects (ON–OFF) for the Successful Stop condition. The activated areas modulated by the stimulation for the 12 patients significantly (P<0.005) are reported as T values on the cortical surface on the N200 and P300 latencies. The blue areas correspond to stronger activations in OFF than ON stimulation conditions and reciprocally, the red areas correspond to stronger activations in ON than OFF stimulation conditions. DBS, deep brain stimulation.
Figure 4Models tested by dynamic casual modeling on the successful stop trials for both conditions of DBS. The nine tested models were grouped by families depending on the entry to the basal ganglia on which the modulation by DBS was tested: either the inferior frontal gyrus (IFG) or the pre-supplementary motor area (preSMA)/dorsal anterior cingulate cortex (dACC). Bayesian model selection results are displayed for each model and each family of models. BG, basal ganglia; DBS, deep brain stimulation; DLPFC, dorsolateral prefrontal cortex.
Figure 5Group averaged dynamic casual modeling time series and effective connectivity on the most probable family (after Bayesian model selection), averaged over the three models of this family. Connectivity weights from the Bayesian model averaging posteriors are indicated on each arrow (exponential of the mean connectivity over all the patients). Asterisk stands for P<0.05 in a paired t-test between stimulation conditions (on the amplitude time series and connectivity weights). BG, basal ganglia; dACC, dorsal anterior cingulate cortex; DLPFC, dorsolateral prefrontal cortex; IFG, inferior frontal gyrus; preSMA, pre-supplementary motor area.